Ambrisentan tablets bulk supplier for pharma manufacturers

Ambrisentan Tablets 5 mg and 10 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 5 mg and 10 mg

Reference Brands: Letairis®(US & EU); Volibris®(EU)

Ambrisentan is an endothelin receptor antagonist that blocks endothelin-1, a substance that constricts blood vessels. It relaxes pulmonary arteries, decreasing blood pressure. Benefits include improved exercise capacity, symptom relief, and slowed disease progression in pulmonary arterial hypertension patients, enhancing quality of life.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Ambrisentan tablets, marketed as Letairis® and Volibris®, are approved in the US and EU for pulmonary arterial hypertension (PAH). Regulatory dossiers include comprehensive clinical trial data, manufacturing standards, and safety profiles, supporting approval by the FDA and EMA. These dossiers demonstrate Ambrisentan’s efficacy in improving exercise capacity and reducing PAH symptoms. Available in 5 mg and 10 mg tablets, dosing can be tailored to patient response. For detailed insights on regulatory processes, dossier submissions, and market approvals in the EU and US, visit PharmaTradz, your trusted source for pharmaceutical regulatory insights and industry updates.

Ambrisentan Tablets — third party manufacturing & bulk supply

Ambrisentan Tablets 5 mg and 10 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Ambrisentan Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Ambrisentan Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Ambrisentan Tablets →

Back to Listing

Frequently Asked Questions

Ambrisentan tablets is listed as Tablets in 5 mg and 10 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Ambrisentan tablets is referenced against Letairis®(US & EU); Volibris®(EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.